Cite
RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.
MLA
Lin, Chun‐Yuan, et al. “Risk of New Onset Type Ii Dm in Mdd Patients Receiving Second-Generation Antipsychotics Treatment: A Nationwide Cohort Study.” Depression & Anxiety (1091-4269), vol. 33, no. 5, May 2016, pp. 435–43. EBSCOhost, https://doi.org/10.1002/da.22489.
APA
Lin, C., Wu, Y., Wang, H., Chen, P., Lin, Y., & Chien, I. (2016). Risk of New Onset Type Ii Dm in Mdd Patients Receiving Second-Generation Antipsychotics Treatment: A Nationwide Cohort Study. Depression & Anxiety (1091-4269), 33(5), 435–443. https://doi.org/10.1002/da.22489
Chicago
Lin, Chun‐Yuan, Yu‐Hsin Wu, Hong‐Song Wang, Ping‐Kun Chen, Yuan‐Fu Lin, and I‐Chia Chien. 2016. “Risk of New Onset Type Ii Dm in Mdd Patients Receiving Second-Generation Antipsychotics Treatment: A Nationwide Cohort Study.” Depression & Anxiety (1091-4269) 33 (5): 435–43. doi:10.1002/da.22489.